Open for inclusion

Open-Label, Multi-Center, Phase 2 Study of Anti-CCR4 Monoclonal AntibodyKW-0761(mogamulizumab) in Subjects with Previously Treated Peripheral T-Cell Lymphoma (PTCL)

Cancer type: Lymphoma

Phase: II

Principal Investigator: dAmore Francesco

Country: DK

Keywords: Denmark, Aarhus

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01611142?term=0761-007&rank=1